Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Syed Md Akram Hussain, Md Shuayb, Mahmudur Rahman
International Journal of Molecular & Immuno Oncology, doi:10.25259/ijmio_30_2020
is is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
References
Caly, Druce, Catton, Jans, Wagstaff, e FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Res
Cortiula, Pettke, Bartoletti, Puglisi, Helleday, Managing COVID-19 in the oncology clinic and avoiding the distraction effect, Ann Oncol
Hussain, Shuayb, Rahman, Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh, Int J Mol Immuno Oncol,
doi:10.25259/IJMIO_30_2020Hussman, Cellular and Molecular Pathways of COVID-19 and Potential Points of erapeutic Intervention, Front Pharmacol
Maurya, A Combination of Ivermectin and Doxycycline Possibly Blocks the Viral Entry and Modulate the Innate Immune Response in COVID-19 Patients
{ 'indexed': {'date-parts': [[2023, 3, 20]], 'date-time': '2023-03-20T07:12:57Z', 'timestamp': 1679296377498},
'reference-count': 3,
'publisher': 'Scientific Scholar',
'content-domain': {'domain': ['ijmio.com'], 'crossmark-restriction': True},
'DOI': '10.25259/ijmio_30_2020',
'type': 'journal-article',
'created': {'date-parts': [[2020, 12, 2]], 'date-time': '2020-12-02T12:39:43Z', 'timestamp': 1606912783000},
'page': '27-29',
'update-policy': 'http://dx.doi.org/10.25259/crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in '
'Bangladesh',
'prefix': '10.25259',
'volume': '6',
'author': [ { 'given': 'Syed Md Akram',
'family': 'Hussain',
'sequence': 'first',
'affiliation': [ { 'name': 'Department of Oncology, Square Hospitals, West Panthapath, '
'Dhaka, Bangladesh,'}]},
{ 'given': 'Md',
'family': 'Shuayb',
'sequence': 'additional',
'affiliation': [ { 'name': 'Vancouver Prostate Centre, Vancouver General Hospital, The '
'University of British Columbia, Vancouver, Canada,'}]},
{ 'given': 'Mahmudur',
'family': 'Rahman',
'sequence': 'additional',
'affiliation': [ { 'name': 'Emerging Infections Program, IDD, International Centre for '
'Diarrhoeal Disease Research, Mohakhali, Dhaka, Bangladesh,'}]}],
'member': '10894',
'published-online': {'date-parts': [[2021, 1, 8]]},
'reference': [ { 'key': '10.25259/IJMIO_30_2020/ref-2',
'doi-asserted-by': 'publisher',
'first-page': '104787',
'DOI': '10.1016/j.antiviral.2020.104787',
'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 '
'in vitro',
'volume': '178',
'author': 'Caly',
'year': '2020',
'journal-title': 'Antiviral Res'},
{ 'key': '10.25259/IJMIO_30_2020/ref-4',
'doi-asserted-by': 'publisher',
'first-page': '1169',
'DOI': '10.3389/fphar.2020.01169',
'article-title': 'Cellular and Molecular Pathways of COVID-19 and Potential Points of '
'Therapeutic Intervention',
'volume': '11',
'author': 'Hussman',
'year': '2020',
'journal-title': 'Front Pharmacol'},
{ 'key': '10.25259/IJMIO_30_2020/ref-5',
'doi-asserted-by': 'publisher',
'first-page': '553',
'DOI': '10.1016/j.annonc.2020.03.286',
'article-title': 'Managing COVID-19 in the oncology clinic and avoiding the distraction '
'effect',
'volume': '31',
'author': 'Cortiula',
'year': '2020',
'journal-title': 'Ann Oncol'}],
'container-title': 'International Journal of Molecular and Immuno Oncology',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://ijmio.com/outcome-of-ivermectin-and-doxycycline-in-cancer-patients-with-coronavirus-disease-2019-a-positive-experience-in-bangladesh/',
'content-type': 'text/html',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://ijmio.com/outcome-of-ivermectin-and-doxycycline-in-cancer-patients-with-coronavirus-disease-2019-a-positive-experience-in-bangladesh/',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2023, 3, 20]],
'date-time': '2023-03-20T06:29:39Z',
'timestamp': 1679293779000},
'score': 1,
'resource': { 'primary': { 'URL': 'https://ijmio.com/outcome-of-ivermectin-and-doxycycline-in-cancer-patients-with-coronavirus-disease-2019-a-positive-experience-in-bangladesh/'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 1, 8]]},
'references-count': 3,
'alternative-id': ['10.25259/IJMIO_30_2020'],
'URL': 'http://dx.doi.org/10.25259/IJMIO_30_2020',
'relation': {},
'ISSN': ['2456-3994'],
'subject': [],
'container-title-short': 'IJMIO',
'published': {'date-parts': [[2021, 1, 8]]},
'article-number': '27'}
